Year: 2015
Type: article
Study design: Observational Study
Abstract: Alexander disease is a rare, progressive, and generally fatal neurological disorder that results from dominant mutations affecting the coding region of GFAP, the gene encoding glial fibrillary acidic protein, the major intermediate filament protein of astrocytes in the CNS. A key step in pathogenesis appears to be the accumulation of GFAP within astrocytes to excessive levels. Studies using mouse models indicate that the severity of the phenotype correlates with the level of expression, and suppression of GFAP expression and/or accumulation is one strategy that is being pursued as a potential treatment. With the goal of identifying biomarkers that indirectly reflect the levels of GFAP in brain parenchyma, we have assayed GFAP levels in two body fluids in humans that are readily accessible as biopsy sites: CSF and blood. We find that GFAP levels are consistently elevated in the CSF of patients with Alexander disease, but only occasionally and modestly elevated in blood. These results provide the foundation for future studies that will explore whether GFAP levels can serve as a convenient means to monitor the progression of disease and the response to treatment.
Source: eNeuro
Authors: Paige L. Jany, Guillermo E. Agosta, William S. Benko, Jens C. Eickhoff, Stephanie R. Keller, Wolfgang Köehler, David Koeller, Soe Mar, Sakkubai Naidu, Jayne Marie Ness, Davide Pareyson, Deborah L. Renaud, Ettore Salsano, Raphael Schiffmann, Julie Simon, Adeline Vanderver, Florian Eichler, Marjo S. van der Knaap, Albee Messing
Institutions: University of Wisconsin–Madison, Hospital Italiano de Buenos Aires, Universidad Hospital Italiano, National Institutes of Health, National Institute of Neurological Disorders and Stroke, Emory University, Oregon Health & Science University, Washington University in St. Louis, Johns Hopkins University, Johns Hopkins Medicine, University of Alabama, University of Alabama at Birmingham, Fondazione IRCCS Istituto Neurologico Carlo Besta, Mayo Clinic, MultiCare Health System, Children's National, Massachusetts General Hospital, Amsterdam UMC Location Vrije Universiteit Amsterdam
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,925
Funders: Waisman Center, National Institutes of Health, National Institute of Neurological Disorders and Stroke, National Institute of Child Health and Human Development, National Center for Advancing Translational Sciences, Eunice Kennedy Shriver National Institute of Child Health and Human Development
OpenAlex ID: W2184491519
